![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:GABRA5-NOV (FusionGDB2 ID:HG2558TG6134) |
Fusion Gene Summary for GABRA5-NOV |
![]() |
Fusion gene information | Fusion gene name: GABRA5-NOV | Fusion gene ID: hg2558tg6134 | Hgene | Tgene | Gene symbol | GABRA5 | NOV | Gene ID | 2558 | 6134 |
Gene name | gamma-aminobutyric acid type A receptor subunit alpha5 | ribosomal protein L10 | |
Synonyms | EIEE79 | AUTSX5|DXS648|DXS648E|L10|MRXS35|NOV|QM | |
Cytomap | ('GABRA5')('NOV') 15q12 | Xq28 | |
Type of gene | protein-coding | protein-coding | |
Description | gamma-aminobutyric acid receptor subunit alpha-5GABA(A) receptor subunit alpha-5gamma-aminobutyric acid (GABA) A receptor, alpha 5gamma-aminobutyric acid type A receptor alpha5 subunit | 60S ribosomal protein L10Wilms tumor-related proteinlaminin receptor homologlarge ribosomal subunit protein uL16tumor suppressor QM | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | P31644 | . | |
Ensembl transtripts involved in fusion gene | ENST00000557449, ENST00000335625, ENST00000355395, ENST00000400081, | ||
Fusion gene scores | * DoF score | 2 X 3 X 2=12 | 3 X 3 X 3=27 |
# samples | 2 | 3 | |
** MAII score | log2(2/12*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: GABRA5 [Title/Abstract] AND NOV [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | GABRA5(27114481)-NOV(120428626), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ACC | TCGA-OR-A5JY-01A | GABRA5 | chr15 | 27114480 | + | NOV | chr8 | 120428625 | + |
ChimerDB4 | ACC | TCGA-OR-A5JY-01A | GABRA5 | chr15 | 27114481 | + | NOV | chr8 | 120428626 | + |
Top |
Fusion Gene ORF analysis for GABRA5-NOV |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-5UTR | ENST00000557449 | ENST00000259526 | GABRA5 | chr15 | 27114480 | + | NOV | chr8 | 120428625 | + |
3UTR-5UTR | ENST00000557449 | ENST00000259526 | GABRA5 | chr15 | 27114481 | + | NOV | chr8 | 120428626 | + |
5CDS-5UTR | ENST00000335625 | ENST00000259526 | GABRA5 | chr15 | 27114480 | + | NOV | chr8 | 120428625 | + |
5CDS-5UTR | ENST00000335625 | ENST00000259526 | GABRA5 | chr15 | 27114481 | + | NOV | chr8 | 120428626 | + |
5CDS-5UTR | ENST00000355395 | ENST00000259526 | GABRA5 | chr15 | 27114480 | + | NOV | chr8 | 120428625 | + |
5CDS-5UTR | ENST00000355395 | ENST00000259526 | GABRA5 | chr15 | 27114481 | + | NOV | chr8 | 120428626 | + |
5CDS-5UTR | ENST00000400081 | ENST00000259526 | GABRA5 | chr15 | 27114480 | + | NOV | chr8 | 120428625 | + |
5CDS-5UTR | ENST00000400081 | ENST00000259526 | GABRA5 | chr15 | 27114481 | + | NOV | chr8 | 120428626 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for GABRA5-NOV |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for GABRA5-NOV |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:27114481/:120428626) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
GABRA5 | . |
FUNCTION: Ligand-gated chloride channel subunit which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:29961870, PubMed:31056671). May be involved in GABA-A receptor assembly, and GABA-A receptor immobilization and accumulation by gephyrin at the synapse (PubMed:31056671). {ECO:0000269|PubMed:29961870, ECO:0000269|PubMed:31056671}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for GABRA5-NOV |
![]() |
Top |
Fusion Gene PPI Analysis for GABRA5-NOV |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GABRA5-NOV |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GABRA5 | P31644 | DB00395 | Carisoprodol | Modulator | Small molecule | Approved |
Hgene | GABRA5 | P31644 | DB00849 | Methylphenobarbital | Potentiator | Small molecule | Approved |
Hgene | GABRA5 | P31644 | DB00898 | Ethanol | Small molecule | Approved | |
Hgene | GABRA5 | P31644 | DB01198 | Zopiclone | Potentiator | Small molecule | Approved |
Hgene | GABRA5 | P31644 | DB01205 | Flumazenil | Antagonist | Small molecule | Approved |
Hgene | GABRA5 | P31644 | DB00241 | Butalbital | Potentiator | Small molecule | Approved|Illicit |
Hgene | GABRA5 | P31644 | DB00306 | Talbutal | Potentiator | Small molecule | Approved|Illicit |
Hgene | GABRA5 | P31644 | DB00371 | Meprobamate | Agonist | Small molecule | Approved|Illicit |
Hgene | GABRA5 | P31644 | DB01351 | Amobarbital | Potentiator | Small molecule | Approved|Illicit |
Hgene | GABRA5 | P31644 | DB01353 | Butobarbital | Potentiator | Small molecule | Approved|Illicit |
Hgene | GABRA5 | P31644 | DB00402 | Eszopiclone | Agonist | Small molecule | Approved|Investigational |
Hgene | GABRA5 | P31644 | DB00312 | Pentobarbital | Potentiator | Small molecule | Approved|Investigational|Vet_approved |
Hgene | GABRA5 | P31644 | DB00418 | Secobarbital | Potentiator | Small molecule | Approved|Vet_approved |
Hgene | GABRA5 | P31644 | DB00599 | Thiopental | Potentiator | Small molecule | Approved|Vet_approved |
Hgene | GABRA5 | P31644 | DB00794 | Primidone | Potentiator | Small molecule | Approved|Vet_approved |
Top |
Related Diseases for GABRA5-NOV |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GABRA5 | C0005586 | Bipolar Disorder | 5 | PSYGENET |
Hgene | GABRA5 | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Hgene | GABRA5 | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | GABRA5 | C0022333 | Jacksonian Seizure | 1 | CTD_human |
Hgene | GABRA5 | C0025261 | Memory Disorders | 1 | CTD_human |
Hgene | GABRA5 | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | GABRA5 | C0036572 | Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0149958 | Complex partial seizures | 1 | CTD_human |
Hgene | GABRA5 | C0150080 | Social Communication Disorder | 1 | CTD_human |
Hgene | GABRA5 | C0233794 | Memory impairment | 1 | CTD_human |
Hgene | GABRA5 | C0234533 | Generalized seizures | 1 | CTD_human |
Hgene | GABRA5 | C0234535 | Clonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0270824 | Visual seizure | 1 | CTD_human |
Hgene | GABRA5 | C0270844 | Tonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0270846 | Epileptic drop attack | 1 | CTD_human |
Hgene | GABRA5 | C0422850 | Seizures, Somatosensory | 1 | CTD_human |
Hgene | GABRA5 | C0422852 | Seizures, Auditory | 1 | CTD_human |
Hgene | GABRA5 | C0422853 | Olfactory seizure | 1 | CTD_human |
Hgene | GABRA5 | C0422854 | Gustatory seizure | 1 | CTD_human |
Hgene | GABRA5 | C0422855 | Vertiginous seizure | 1 | CTD_human |
Hgene | GABRA5 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
Hgene | GABRA5 | C0494475 | Tonic - clonic seizures | 1 | CTD_human |
Hgene | GABRA5 | C0525045 | Mood Disorders | 1 | PSYGENET |
Hgene | GABRA5 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | GABRA5 | C0751056 | Non-epileptic convulsion | 1 | CTD_human |
Hgene | GABRA5 | C0751110 | Single Seizure | 1 | CTD_human |
Hgene | GABRA5 | C0751123 | Atonic Absence Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0751292 | Age-Related Memory Disorders | 1 | CTD_human |
Hgene | GABRA5 | C0751293 | Memory Disorder, Semantic | 1 | CTD_human |
Hgene | GABRA5 | C0751294 | Memory Disorder, Spatial | 1 | CTD_human |
Hgene | GABRA5 | C0751295 | Memory Loss | 1 | CTD_human |
Hgene | GABRA5 | C0751494 | Convulsive Seizures | 1 | CTD_human |
Hgene | GABRA5 | C0751495 | Seizures, Focal | 1 | CTD_human |
Hgene | GABRA5 | C0751496 | Seizures, Sensory | 1 | CTD_human |
Hgene | GABRA5 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Hgene | GABRA5 | C3495874 | Nonepileptic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C3711376 | Isodicentric Chromosome 15 Syndrome | 1 | CTD_human |
Hgene | GABRA5 | C4048158 | Convulsions | 1 | CTD_human |
Hgene | GABRA5 | C4316903 | Absence Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4317109 | Epileptic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4317123 | Myoclonic Seizures | 1 | CTD_human |
Hgene | GABRA5 | C4505436 | Generalized Absence Seizures | 1 | CTD_human |